NMRNomura Holdings, Inc.

$9.60+29% 1Y

NMR as reported

Nomura Holdings, Inc. reported JPY 4.76T of revenue over the trailing twelve months, +0.46% on the year before. 9 reported series are charted on this page, each one as filed.

JPY 4.76T

Revenue, trailing twelve months · to FY2026 · +0.46% against the twelve months before

Net income
JPY 362.1B

Net income · +6.3% year on year · trailing twelve months to FY2026

Free cash flow
−JPY 1.20T

Free cash flow · +38% year on year · trailing twelve months to FY2026

Operating margin
66%

Operating margin · trailing twelve months to FY2026

Details›
Every series Ryufin has for NMR, trailing twelve months
SeriesLatestYear on yearAs of
RevenueJPY 4.76T+0.46%FY2026
Net incomeJPY 362.1B+6.3%FY2026
EPSJPY 118.99+7.2%FY2026
Operating margin66%n/aFY2026
Net margin7.6%n/aFY2026
ROE9.8%n/aFY2026
ROA0.58%n/aFY2026
ROIC15%n/aFY2026
Free cash flow−JPY 1.20T+38%FY2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.

Revenue and profitNomura Holdings, Inc. (NMR)
RevenueNet incomeTrailing twelve months
Powered byryufin.com